Also categorized in BoardNews:
Getting Gen-Y on Boards (of Directors)
x hide permanently

Allergan Said to Revive Discussions to Buy Salix Pharmaceuticals


The Botox-maker’s talks with Salix went dormant for a few weeks because Salix wanted a higher price than Allergan wanted to pay, said the people, who asked not to be identified discussing private information. While the talks are active again, a deal may not be reached...

Mentions: Management hostile takeover MDC Partners